169 related articles for article (PubMed ID: 29855219)
1. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats.
Širka A; Raina DB; Isaksson H; Tanner KE; Smailys A; Kumar A; Tarasevičius Š; Tägil M; Lidgren L
Tissue Eng Part A; 2018 Dec; 24(23-24):1753-1764. PubMed ID: 29855219
[TBL] [Abstract][Full Text] [Related]
2. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.
Raina DB; Širka A; Qayoom I; Teotia AK; Liu Y; Tarasevicius S; Tanner KE; Isaksson H; Kumar A; Tägil M; Lidgren L
Tissue Eng Part A; 2020 Oct; 26(19-20):1042-1051. PubMed ID: 32242474
[TBL] [Abstract][Full Text] [Related]
4. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
5. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
6. Biomodulation of an implant for enhanced bone-implant anchorage.
Raina DB; Larsson D; Sezgin EA; Isaksson H; Tägil M; Lidgren L
Acta Biomater; 2019 Sep; 96():619-630. PubMed ID: 31301423
[TBL] [Abstract][Full Text] [Related]
7. Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation.
Markeviciute V; Puthia M; Arvidsson L; Liu Y; Törnquist E; Tengattini A; Huang J; Bai Y; Vater C; Petrolis R; Zwingenberger S; Krisciukaitis A; Smailys A; Lukosevicius S; Stravinskas M; Isaksson H; Tarasevicius S; Lidgren L; Tägil M; Raina DB
Acta Biomater; 2024 Apr; 179():354-370. PubMed ID: 38490481
[TBL] [Abstract][Full Text] [Related]
8. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Yang JH; Kim HJ; Kim SE; Yun YP; Bae JH; Kim SJ; Choi KH; Song HR
Cytotherapy; 2012 Mar; 14(3):315-26. PubMed ID: 22122301
[TBL] [Abstract][Full Text] [Related]
9. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Raina DB; Isaksson H; Teotia AK; Lidgren L; Tägil M; Kumar A
J Control Release; 2016 Aug; 235():365-378. PubMed ID: 27252151
[TBL] [Abstract][Full Text] [Related]
10. A Biphasic Calcium Sulphate/Hydroxyapatite Carrier Containing Bone Morphogenic Protein-2 and Zoledronic Acid Generates Bone.
Raina DB; Isaksson H; Hettwer W; Kumar A; Lidgren L; Tägil M
Sci Rep; 2016 May; 6():26033. PubMed ID: 27189411
[TBL] [Abstract][Full Text] [Related]
11. The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.
Liporace FA; Breitbart EA; Yoon RS; Doyle E; Paglia DN; Lin S
J Orthop Traumatol; 2015 Jun; 16(2):151-9. PubMed ID: 25421865
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of zoledronate on early-stage osteoinduction by recombinant human bone morphogenetic protein 2 in an osteoporosis model.
Lee JH; Baek HR; Lee KM; Zheng GB; Shin SJ; Jin YZ
Growth Factors; 2015; 33(3):220-8. PubMed ID: 26099999
[TBL] [Abstract][Full Text] [Related]
14. Cancellous bone healing around strontium-doped hydroxyapatite in osteoporotic rats previously treated with zoledronic acid.
Li Y; Shui X; Zhang L; Hu J
J Biomed Mater Res B Appl Biomater; 2016 Apr; 104(3):476-81. PubMed ID: 25891947
[TBL] [Abstract][Full Text] [Related]
15.
Horstmann PF; Raina DB; Isaksson H; Hettwer W; Lidgren L; Petersen MM; Tägil M
Tissue Eng Part A; 2017 Dec; 23(23-24):1403-1412. PubMed ID: 28537526
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.
Li H; Zhou Q; Bai BL; Weng SJ; Wu ZY; Xie ZJ; Feng ZH; Cheng L; Boodhun V; Yang L
J Bone Miner Metab; 2018 Nov; 36(6):691-699. PubMed ID: 29280077
[TBL] [Abstract][Full Text] [Related]
17. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.
Raina DB; Matuszewski LM; Vater C; Bolte J; Isaksson H; Lidgren L; Tägil M; Zwingenberger S
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33246951
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.
Liu X; Bao C; Xu HHK; Pan J; Hu J; Wang P; Luo E
Acta Biomater; 2016 Sep; 42():378-388. PubMed ID: 27318268
[TBL] [Abstract][Full Text] [Related]
19. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
[TBL] [Abstract][Full Text] [Related]
20. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
Seeherman HJ; Li XJ; Smith E; Parkington J; Li R; Wozney JM
J Bone Joint Surg Am; 2013 Jan; 95(1):36-47. PubMed ID: 23283371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
